MedTrace Logo

Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye

NCT03436576 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-09-05

No results posted yet for this study

Summary

The purpose of this study is to compare the effects of autologous serum 20% and autologous serum 50% for the treatment of Severe Dry Eye Syndrome

Conditions

  • Dry Eye
  • Keratoconjunctivitis Sicca
  • Sjogren's Syndrome
  • Corneal Diseases
  • Conjunctival Diseases
  • Keratitis
  • Lacrimal Apparatus Diseases

Interventions

DRUG

Autologous Serum 20%

Instillation of 1 drop of Autologous Serum 20% four times a day

DRUG

Autologous Serum 50%

Instillation of 1 drop of Autologous Serum 50% four times a day

Sponsors & Collaborators

  • Hospital Dr Sotero del Rio

    collaborator OTHER

  • Pontificia Universidad Catolica de Chile

    lead OTHER

Principal Investigators

  • Paulina Liberman, MD · Pontificia Universidad Catolica de Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-12
Primary Completion
2018-10-19
Completion
2018-11-19

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03436576 on ClinicalTrials.gov